Synovis Micro Companies Alliance (Synovis MCA), a subsidiary of Baxter International, has been selected to exclusively distribute Polyganics' nerve capping device across the US.
11 Sep 2018
06 Sep 2018
Bioelectronic medicine firm PathMaker Neurosystems has commenced the European clinical study to assess MyoRegulator neuromodulation device for the non-invasive treatment of spasticity secondary to stroke.
04 Sep 2018
Regenerative medicines developerSanBio Group has acquired patent portfolio related to cell medicines derived from mesenchymal stem cells (MSCs).
03 Sep 2018
BlueWind Medical has reported positive results from a follow-up study of patients using its implantable tibial nerve neuromodulator for the management of overactive bladder (OAB).
30 Aug 2018
Hesperos has received NIH Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health’s (NIH) National Institute on Aging (NIA) to develop a new multi-organ ‘human-on-a-chip’ model to test Alzheimer’s disease (AD) drugs.
27 Aug 2018
Arkansas Children's Hospital has signed an agreement with MEGIN (formerly Elekta Oy) to acquire a TRIUX neo for functional brain imaging.
22 Aug 2018
Two separate expert panels have recommended Global Kinetics’ wearable technology, the Personal KinetiGraph (PKG) for routine management of Parkinson’s disease.
17 Aug 2018
Medtronic said treatment with ITB therapy vs. oral medication demonstrated quality of life improvement
Medtronic has said that treatment with Intrathecal Baclofen Therapy (ITB therapy) vs. oral medication demonstrated quality of life improvement and reduction in spasticity-related pain.
13 Aug 2018
NICO has launched an Investigator Initiated Study (IIS) Program that offers financial support for prospective studies or the assessment of retrospective data related to improved patient and economic outcomes using minimally invasive neurosurgery approaches.
08 Aug 2018
Cerveau Technologies has expanded the production network for its tau imaging agent [18F]MK-6240, an investigational imaging agent to be utilized in positron emission tomography (PET) scans to evaluate the status and progression of neurofibrillary tangles (NFTs) in the brain.